-
PFA ependymoma cancer study
Study
EGAS00001004312
-
Whole exome sequencing data of patients with resectable esophageal adenocarcinoma treated with neoadjuvant atezolizumab and chemoradiation (PERFECT)
Study
EGAS00001006504
-
Targeted sequencing of head and neck squamous cell carcinomas
Study
EGAS00001002979
-
Efficacy of two different FGFR-inhibitors in a patient with extrahepatic cholangiocarcinoma harboring an FGFR2 mutation
Study
EGAS50000000015
-
Aberrant EZHIP Expression Drives Tumorigenesis in Osteosarcoma
Study
EGAS00001007531
-
Single-cell RNA seq-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma
Study
EGAS50000000838
-
RNAseq of Follicular Lymphoma
Study
EGAS00001002980
-
Whole exome sequencing of Ewing and CIC-DUX4 sarcoma tumoroid models
Study
EGAS50000000379
-
RNA sequencing of Ewing and CIC-DUX4 sarcoma tumoroid models
Study
EGAS50000000380
-
CRISPR_screen_M14__NCI_H3122
Study
EGAS00001001060